Prevention of Postpartum Hemorrhage with TXA
common.study.values.description
“Prevention of Postpartum Hemorrhage With TXA”
Hemorrhage remains the leading cause of maternal death worldwide. Tranexamic acid has been shown to reduce rates of hemorrhage when given prophylactically prior to cesarean delivery. It has also been shown to be an effective treatment in response to hemorrhage after a vaginal delivery. The aim of this study is to assess the impact of TXA on hemorrhage rates when given prophylactically prior to all deliveries.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-no
Drug - Tranexamic Acid 1000 mg/10ml normal saline infusion
Infusion of Tranexamic Acid (Cyklokapron) to all consented women with the delivery of the anterior shoulder of the infant
participant.views.study.view.additional
participant.views.study.view.scientific-title
Prevention of Postpartum Hemorrhage With Tranexamic Acid (TXA)
common.study.values.clinical-trial-id
NCT03326596
participant.views.study.view.id
1aKpzb
